Bhalla, K S <br/><br/>
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Jan 2000 
 - 17-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1073-449X 
<br/><br/><label>Standard No.: </label>10.1164/ajrccm.161.1.9903059  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--therapy<br/>Adult<br/>Antigens, CD--metabolism<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Transplantation<br/>Breast Neoplasms--therapy<br/>Bronchoalveolar Lavage Fluid--chemistry<br/>Bronchoscopy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Interleukin-6--metabolism<br/>Interleukin-8--metabolism<br/>Lung--drug effects<br/>Lymphocytes--metabolism<br/>Neutrophils--metabolism<br/>Prednisone--therapeutic use<br/>Receptors, Tumor Necrosis Factor--metabolism<br/>Receptors, Tumor Necrosis Factor, Type I<br/>Respiratory Distress Syndrome--chemically induced<br/>Respiratory Function Tests<br/>Retrospective Studies<br/>Transplantation, Autologous